Senzime AB (publ)
SEZI
Rank in Stocks
#22250
Senzime AB (publ) is a medical technology firm specializing in the creation and... Senzime AB (publ) is a medical technology firm specializing in the creation and distribution of advanced patient monitoring solutions. These systems are designed to oversee patients undergoing anesthesia across various global markets, including Europe, Oceania, Asia, Canada, and the United States. Among its primary offerings is the TetraGraph, a sophisticated monitor designed to assess and display muscle function in surgical patients administered neuromuscular blocking agents, by stimulating, measuring, and analyzing responses. This system is complemented by the TetraSens electrode array, featuring two proximal stimulating electrodes for precise recording and reference. For data management, TetraConnect serves as a portal, allowing clinicians to conveniently access, view, and export TetraGraph data records in PDF or Excel formats. Furthermore, TetraGraph Device Connectivity facilitates the transfer of data from the TetraGraph Monitor to other patient monitoring systems, while the TetraGraph Philips Interface specifically enables the transmission of critical neuromuscular monitoring parameters—such as TOFC, TOFR, PTC, and TOF bars—to Philips patient monitors, with readings visible on the Philips Intellivue Monitor. Senzime is also actively developing the CliniSenz Analyzer, intended for continuous postoperative patient monitoring within hospital settings. Another innovation in its pipeline is the Onzurf Probe, a sterile, CE-marked single-use device leveraging micro-dialysis technology for continuous sampling from gastrointestinal organs, including the esophagus, stomach, and liver. The company maintains a strategic licensing and connectivity partnership with Masimo. This collaboration focuses on developing and commercializing the TetraGraph Smart Cable Module, designed to integrate seamlessly with Masimo's Root monitoring system and their digital hubs, thereby enabling interaction with hospital clinical information systems and electronic health records. Established in 1999, Senzime AB (publ) operates from its headquarters in Uppsala, Sweden.
Share Price
$0.34971985
Last synced: 2026-11-13
Market Cap
$54.98M
Change (1 day)
-3.15%
Change (1 year)
-33.88%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Senzime AB (publ) (SEZI)
Category
Healthcare
EPS for Senzime AB (publ) (SEZI)
EPS as of September 2026 TTM: $-0.06
According to Senzime AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.10, a decrease compared to its 2024 EPS of $-0.09.
EPS history for Senzime AB (publ) from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | -38.50% |
| 2025 | $-0.10 | 14.68% |
| 2024 | $-0.09 | -38.83% |
| 2023 | $-0.14 | -23.56% |
| 2022 | $-0.19 | 30.92% |
| 2021 | $-0.14 | 43.03% |
| 2020 | $-0.10 | 42.01% |
| 2019 | $-0.07 | 7.12% |
| 2018 | $-0.07 | 63.37% |
| 2017 | $-0.04 | 11.29% |
| 2016 | $-0.04 | -37.52% |
| 2015 | $-0.06 | 5.44% |
| 2014 | $-0.06 | -17.51% |
| 2013 | $-0.07 | 14.38% |
| 2012 | $-0.06 | 74.85% |
| 2011 | $-0.03 | -29.98% |
| 2010 | $-0.05 | 6.47% |
| 2009 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -4,490.24% |
US
|
|
| $4.09 | -6,750.41% |
IE
|
|
| $9.45 | -15,465.85% |
US
|
|
| $2.37 | -3,953.66% |
US
|
|
| $1.77 | -2,978.05% |
US
|
Questions about Senzime AB (publ)'s earnings per share (EPS)
What is Senzime AB (publ)'s earnings per share (EPS)?
Senzime AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.06, as of Sep 2026.
What was Senzime AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Senzime AB (publ)'s earnings per share (EPS) was $-0.10, compared with $-0.09 in 2024.
How has Senzime AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Senzime AB (publ)'s earnings per share (EPS) was highest in 2024 ($-0.09) and lowest in 2022 ($-0.19).
How does Senzime AB (publ)'s earnings per share (EPS) compare with similar companies?
Senzime AB (publ)'s earnings per share (EPS) ($-0.06) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.